LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $9 million in its third quarter. On a per-share basis, the Lexington, Massachusetts-based ...

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a ...

Allspring Global Investments Holdings LLC cut its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 66.5% ...

The market expects Voyager Therapeutics (VYGR) to deliver a year-over-year increase ... but a powerful factor that might influence its near-term stock price is how the actual results compare ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Voyager Therapeutics (VYGR – Research Report), Align Tech ...

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago ...

Analysts expect Voyager Therapeutics to report an earnings per share (EPS) of $-0.49. Investors in Voyager Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

The market expects Voyager Therapeutics (VYGR) to deliver a year-over-year increase in earnings ... but a powerful factor that might influence its near-term stock price is how the actual results ...

Leerink Partners analyst Lili (Aurélie) Nsongo has maintained their bullish stance on VYGR stock, giving a Buy rating today. Lili (Aurélie) Nsongo’s rating is based on the belief that the ...